These processes occur as a result of smooth muscle cell from proliferation of smooth muscle cells in small peripheral hypertrophy (3), hyperplasia (4), and migration. prostaglandin synthase are protected from the development of hypoxia-induced pulmonary hypertension (12). Prolonged exposure to alveolar hypoxia leads to structural Despite the importance of hypoxia to the development changes in the walls of small pulmonary arteries, known as of pulmonary hypertension, few studies have directly exampulmonary vascular remodeling, and a sustained elevation ined the regulation of pulmonary artery smooth muscle of pulmonary vascular resistance (1). One of the earliest and cell (PASMC) growth by hypoxia. In this study, we have consistent features of hypoxia-induced pulmonary vascular attempted to characterize the effect of hypoxia on growth remodeling in animals (2) and in humans is the extension of human PASMCs isolated from peripheral vessels. In of smooth muscle into previously nonmuscular pulmonary addition, we have examined whether hypoxia regulates the arterioles and increased wall thickness of muscular arteries.
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expression of key enzymes (iNOS, HO-1, and COX-2) involved in the generation of vasoactive factors. Our results suggest that smooth muscle cells from human peripheral pulmonary arteries comprise at least two cell types that (Received in original form May 16, 2002 and in revised form July 16, 2002) may be inhibited or stimulated under hypoxic conditions. distant from the tumor was selected. Only lungs judged by the
Western Blotting
pathologist to have no significant pulmonary vascular disease by Expression of COX isoforms, iNOS, and HO-1 protein in PASMCs light microscopy of tissue sections were used. Distal PASMCs were was assessed by Western blotting, following exposure to normoxia, isolated from peripheral segments of artery (0.3-1.0 mm external hypoxia, interleukin (IL)-1␤, or S-Nitroso-N-acetylpenicillamine diameter) by microdissection, as previously described (13) . Briefly, (SNAP) for up to 72 h. Quiescent cells were exposed to experimenarterial segments and attached branches were carefully separated tal conditions in 0.1%FBS/DMEM in 6-well plates. Cells were from the parenchyma and adventitia, washed in phosphate-buflysed and extracts were boiled at a 1:1 ratio with 2ϫ protein loading fered saline and cut into 2-mm segments. Segments were left to buffer for 5 min. Samples (5 g) were loaded onto 10% (for HO-1) adhere overnight and then maintained in Dulbecco's modified or 7.5% (for iNOS and COX-1/COX-2) SDS-PAGE gels and sepaEagle media (DMEM) in 20% fetal bovine serum (FBS) containing rated by electrophoresis for 1-2 h. The gels were transferred to antibiotic-antimycotic solution. The cells were passed after 2 wk nitrocellulose membrane, incubated with blocking buffer, then into a single 75 cm 2 flask and grown to confluence in DMEM/10% incubated with a specific mouse monoclonal anti-HO-1 (1:1,000) FBS. Approval for studies was obtained from Papworth Hospital (OSA-110; Stressgen Biotechnologies Corp., York, UK), rabbit Ethical Review Board. For experiments PASMCs were plated in polyclonal anti-iNOS (1:1,000), goat polyclonal anti-COX-1 or DMEM containing 10% FBS and used between passages 3 and anti-COX-2 (1:2,000) (Santa Cruz Biotechnology Inc., Santa Cruz, CA) overnight at 4ЊC. The blots were then incubated with an 10. The smooth muscle lineage of cells was confirmed by positive appropriate horseradish peroxidase-conjugated secondary antiimmunofluorescence staining using antibodies to ␣-smooth muscle body in blocking buffer for 1 h at room temperature. Blots were actin and smooth muscle myosin (Sigma-Aldrich Co Ltd, Poole, developed using enhanced chemiluminescence reagent (Amersham UK) (13) .
Biosciences, Little Chalfont, UK) and rainbow markers were used for molecular weight determinations. In further experiments, the effect of inhibition of activated p38 MAPK on COX-2 induction was
Exposure of Cells to Hypoxia
studied using the water-soluble selective inhibitor SB203580 hydroIn initial experiments PASMCs were grown under standard norchloride (0.1-5 M; Calbiochem, Nottingham, UK). Cells were moxic conditions in a CO 2 incubator, before exposure to hypoxic pretreated for 1 h with SB203580 then exposed to hypoxia for conditions. Hypoxia was induced by pre-gassing cell culture me-24 h. Cell viability in the presence of increasing concentrations of dium (DMEM ϩ 25 mM HEPES) with a gas mixture containing inhibitor was assessed by trypan blue exclusion. 95%N 2 /5%CO 2 for 30 min inside a gas-tight isolator. The hypoxic To determine whether hypoxia activated p38 MAPK in PASMCs, cells were exposed to pre-gassed hypoxic medium for up to 2 h. culture medium was then added to cells plated in 24-or 48-well Protein was harvested by washing cells in cold phosphate-buffered plates. Plates were then maintained inside specially designed persaline and immediately freezing in an ethanol/dry ice bath. Cells spex chambers (Bellco Glass, Inc., Vineland, NJ), gassed with were scraped into 200 l of protein loading buffer containing 95%N 2 /5%CO 2 . Chambers were re-gassed daily. The pH, PO 2 , and protease inhibitors and subjected to SDS-PAGE electrophoresis, PCO 2 in the medium was checked at the beginning and end of as previously described (6, 14) . After washing, blots were incubated each experiment using a blood gas analyzer (ABL5; Radiometer with anti-phospho-p38 MAPK (1:1,000) (Cell Signaling Technology, Ltd, West Sussex, UK). Hypoxic cells were not reoxygenated at Inc., Beverly, MA) overnight at 4ЊC. Blots were then washed and any stage of the experimental procedure.
incubated with an anti-rabbit horseradish peroxidase-conjugated In some experiments, freshly isolated cells or first passage cells secondary antibody (1:2,500; DAKO, Ltd., Ely, UK) for 1 h at were plated in 20%FBS/DMEM in 96-well plates at an approxiroom temperature. Blots were the stripped and re-probed using mate density of 10 cells/well and left to adhere overnight. Plates an antibody to total p38 MAPK (Cell Signaling Technology, Inc.). were then placed under hypoxic conditions as described above and maintained for up to 2-3 wk. Viable, proliferating cells were trypsinized and transferred sequentially to 24-then 6-well plates before passage into T75 cm 2 flasks, while maintaining hypoxic
COX Protein Expression in Pulmonary Arteries
conditions throughout. Lung tissue sections (ϳ 5 ϫ 5 ϫ 3 mm) were obtained from the same surgical resection specimens used for PASMC isolation. Again, results were only included from those sections which were judged by the pathologist to show no evidence for significant pul-
Cell Growth and Proliferation Assays
monary vascular disease. Sections were cut using a razor blade The effect of hypoxia on growth and proliferation of PASMCs and incubated in DMEM at 37ЊC under hypoxic or normoxic was determined by [ 3 H]thymidine incorporation as an index of conditions for 24 and 48 h. Sections were then fixed in 10% phos-DNA synthesis, and cell proliferation was assessed with a hemocyphate-buffered formalin, embedded, and sectioned (3 m). Sectometer. In addition, the effect of hypoxia on the cell cycle was tions were immunostained using antibodies to COX-1 and COX-2 studied by incorporation of propidium iodide and flow cytometry, using a labeled streptavidin biotin peroxidase technique described as described (13) . For [ 3 H]thymidine and proliferation assays cells previously (15) . were plated at 10 4 cells/well in 10%FBS/DMEM in 48-well plates and left to adhere overnight under normoxic conditions. At the beginning of the experimental period, fresh hypoxic or normoxic
Measurement of Prostaglandin Release by Gas
medium was added either alone or containing COX inhibitors. Cells were plated in 6-well plates and grown to subconfluence, The effect of COX inhibition on growth responses to hypoxia then quiesced for 48 h in serum-deprived medium. Cells were then and was tested by coincubating with the nonselective COX inhibiincubated with normoxic or hypoxic 0.1%FBS/DMEM (2 ml/well) tor indomethacin, the selective COX-1 inhibitor valeryl salicylate for 3, 6, 12, 24, 48, or 72 h, in the presence or absence of COX (VS), or the selective COX-2 inhibitor NS398 (Alexis Corporation, inhibitors. The conditioned medium was collected at the end of each time point and immediately frozen at Ϫ70ЊC. Notts, UK). were routed into the electron capture source of a Trio 1000 mass
Chromatography-Mass Spectrometry
The majority of freshly dispersed or first passage distal spectrometer (Thermoquest, San Jose, CA) operated in selected ion mode with ammonia as reagent gas. Deuterated 
Activation of p38MAPK
value of P Ͻ 0.05 indicated statistical significance.
In normoxia-derived cells, immunoblotting for COX isoforms demonstrated constitutive expression of COX-1 un-
Results
der normoxic and hypoxic conditions. In contrast, COX-2 Effect of Hypoxia on Growth of Distal PASMCs expression was minimal in normoxic cells, but was induced in a time-dependent manner under hypoxic conditions In initial experiments, cells were allowed to grow from ( Figure 2 ) and remained elevated for up to 72 h. Exposure explants under standard normoxic conditions. Growth of of normoxia-derived PASMCs to hypoxia did not induce these cells was then assessed under normoxic or hypoxic expression of iNOS or HO-1. Incubation with IL-1␤ also conditions. The respiratory gas tensions and pH of the meinduced COX-2 in these cells and also iNOS, though not dia were: normoxia, pH 7.32 Ϯ 0.07, PCO 2 Because hypoxia has been shown to activate p38 MAPK in conditions, this effect was minimal compared with the inhibition of hypoxia-inducible COX-2 expression (Figure 3 ). pulmonary artery fibroblasts (6, 14) we first confirmed that hypoxia activated P38 MAPK in human PASMCs (Figure 3) .
Effect of Hypoxia on Release of Prostaglandins In addition, incubation of hypoxic PASMCs with SB203580 concentration-dependently inhibited the induction of COX-2
In normoxia-derived cells, release of prostaglandins 6-keto-PGF 1␣ , PGF 2␣ , PGD 2 , and PGE 2 was increased by culture ( Figure 3) . Cell viability studies using trypan blue exclusion demonstrated that concentrations of SB203580 from [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] under hypoxic conditions (Figure 4 ). Increased production of prostaglandins peaked at 12 h but persisted up to 72 h, M had no effect on cell viability. Although there was a small effect of SB203580 on COX-2 expression under normoxic paralleling the time course of induction of COX-2 protein expression. The increase in prostaglandin production in rethe presence of indomethacin or NS398, but not by VS ( Figure 6 ). Similar results were obtained with IL-1␤, in that sponse to hypoxia was markedly inhibited in cells incubated with indomethacin or NS398 for 12 h, but not VS ( Figure 5 ).
COX-2, but not COX-1 inhibition partly reversed the IL-1␤-induced inhibition of DNA synthesis and cell prolifThere was no evidence for isoprostane formation in any of the incubations. As expected, IL-1␤ also increased the eration (data not shown). release of prostaglandins from PASMCs (data not shown).
COX-2 in "Hypoxia-Selected" PASMCs Effect of COX Inhibition on PASMC Growth
We questioned whether the hypoxia-induced proliferation of "hypoxia-selected" PASMCs could be due to failure of In normoxia-derived cells the inhibition of DNA synthesis and cell proliferation induced by hypoxia was reversed in COX-2 induction in these cells. However, "hypoxia-selected" cells demonstrated induction of COX-2 ( Figure 7 ) and indominantly in the endothelium of small pulmonary arteries ( Figure 8 ). The expression of COX-1 was similar under creased release of prostaglandins under hypoxic conditions normoxic and hypoxic conditions. In contrast, COX-2 ex-( Figure 7) . Furthermore, hypoxia-stimulated DNA synthepression was increased in the endothelium of hypoxic artersis in these cells was further augmented by co-incubation ies, and was induced in underlying smooth muscle (Figwith selective or nonselective COX-2 inhibition, but not by ure 8). COX-1 inhibition (Figure 7) .
Demonstration of COX-2 Induction in Intact Arteries

Discussion
Immunohistochemistry of normoxic lung tissue sections
The present study has demonstrated that at least two cell types can be derived from the human peripheral pulmonary demonstrated COX-1, and to a lesser extent COX-2, pre- circulation that differ in their proliferative response to hypthese results suggest that the peripheral pulmonary circulation contains smooth muscle cells that are distinct with oxia. The growth of explant-derived cells was inhibited under hypoxic conditions. However, plating cells at low density regard to their growth under hypoxic conditions. Furthermore, hypoxic induction of COX-2 in peripheral PASMCs under hypoxic conditions allowed proliferation of "hypoxiaselected" cells. Exposure of either cell type to hypoxia did may play a role in the inhibition of pulmonary vascular remodeling during the development of hypoxia-induced not alter expression of COX-1, but induced expression of COX-2, and this was associated with increased production pulmonary hypertension. Several studies have examined the effect of hypoxia on of prostaglandins 6-keto-PGF 1␣ , PGF 2␣ , PGD 2 , and PGE 2 . The induction of COX-2 by hypoxia was at least partly growth of bovine and rat vascular smooth muscle cells (9, (18) (19) (20) (21) and fibroblasts (22) (23) (24) . These studies suggest that dependent on the activation of p38 MAPK . Inhibition of COX-2 activity, but not COX-1, attenuated the hypoxia-induced the fibroblast is readily stimulated to proliferate in response to cellular hypoxia, whereas the smooth muscle cell may increase in prostaglandin release and increased DNA synthesis and proliferation of hypoxic cells. Taken together, require a process of priming, such as serum stimulation (18) or activation of protein kinase C (25). The response of analogs are potent inhibitors of human PASMC proliferation (13) . In the present study, we demonstrated the simultahuman PASMCs to hypoxia has been less extensively studied. One study demonstrated that PASMCs isolated from neous induction of COX-2 and enhanced release of prostaglandins under hypoxic conditions. Inhibition of COX-2 the main pulmonary artery were stimulated to proliferate by 5% O 2 environment, but not 1% O 2 (20) . However, activity was associated with a marked reduction in prostaglandin release and enhanced proliferation of cells under because the time course of equilibration of environmental O 2 with that in the media, and the PO 2 in the media bathing hypoxic conditions. The functional role of hypoxic induction of COX-2 in the cells, is usually not reported in these studies, it is difficult to draw direct comparisons with our observations. vivo remains to be determined, though we have demonstrated the ex vivo induction of COX-2 in organ-cultured Previous reports have focused on the endothelial cell as the main site of increased vascular prostaglandin production lung tissue. Clearly, this requires confirmation in an in vivo under hypoxic conditions (26) . Marked increases in the model. Repeated administration of the nonselective COX release of PGE 2 , PGD 2 , PGF 2␣ , and PGI 2 occur in endotheinhibitor, indomethacin, over a 3-wk period caused suslial cells exposed to hypoxia (27) . Although the induction tained pulmonary hypertension in sheep (34). In addition, of COX-2 by inflammatory cytokines (28) and growth facinfusion of angiotensin II in the chronically hypoxic rat tors (29) is well described in vascular smooth muscle cells, model of pulmonary hypertension prevents acute and this is the first demonstration of the induction of COX-2 chronic increases in pulmonary artery pressure, a protective and increased release of prostaglandins by hypoxia in these effect probably due to increased prostaglandin release (35) . cells. Hypoxia has been shown to induce COX-2 mRNA These studies support the concept that COX products could and protein expression in human umbilical vein endothelial inhibit increases in pulmonary vascular tone and remodeling cells (10) . However, in macrophages, hypoxia inhibits lipoduring the development of pulmonary hypertension. polysaccharide-induced COX-2 expression (30), demon-
The concept of cellular heterogeneity within the pulmostrating the cell-specific nature of hypoxic responses. The nary vascular wall is well established (36), with distinct hypoxic induction of COX-2, at least in endothelial cells, subpopulations of smooth muscle cells in the bovine pulmoappears to involve the cooperation of the transcription facnary artery responding differently in vivo and in vitro. Our tors nuclear factor-B (10), Sp1, and the high-mobilityobservations provide further support for the hypothesis that group protein I(Y) (11) binding to the COX-2 promoter.
multiple cell phenotypes exist in the human pulmonary In bovine (6) and rat (14) pulmonary artery adventitial fiartery that may respond differently to the same stimulus broblasts, hypoxic signaling involves the activation of p38 MAPK , (13) . Cells that proliferate preferentially under hypoxic conthough activation of this stress-associated protein kinase is ditions would have a growth disadvantage under normoxic associated with cell proliferation in these cells. Our data culture conditions, especially if they existed in a minority would indicate that activation of p38 MAPK in human PASMCs in vivo. However, it remains to be established whether the is coupled to growth inhibitory pathways via induction of "hypoxia-selected" cells isolated in this study are repre-COX-2.
sented in the pulmonary vascular wall in vivo. A detailed Our experiments demonstrate the selectivity of hypoxia study comparing the phenotype of these cells, looking for for COX-2 induction in human peripheral PASMCs, in that specific cell markers, or examination of differential gene hypoxia failed to induce expression of iNOS and HO-1.
expression, may help to establish this. Indeed, additional selectivity of specific stimuli to enzyme In summary, this study has demonstrated that PASMCs induction was demonstrated by the induction of COX-2 derived from the human peripheral pulmonary circulation and iNOS, but not HO-1, by IL-1␤, and the induction of differ with regard to their growth under hypoxic conditions, HO-1, but not iNOS or COX-2, by the NO donor, SNAP.
suggesting that the process of hypoxia-induced vascular reIn rat vascular smooth muscle cells, HO-1(31) is induced by modeling in vivo may depend on the net result of growth hypoxia. However, species differences have been observed stimulation and growth suppression. Hypoxic induction of between human and rat smooth muscle cells with regard COX-2 in both cell types increased production of prostato the induction of these enzymes (32) .
glandins and exerts an antiproliferative effect in PASMCs. COX-2 induction by cytokines and growth factors has Inhibition of prostanoid production releases cells from this been shown to regulate the growth of vascular smooth musgrowth inhibitory effect. cle cells (29). However, the effect of COX-2 induction on
